In particular, CRP is positively correlated with the abundance of gut bacteria in lung cancer patients, indicating that the elevated level of inflammatory components in peripheral blood may serve as a risk indication for lung cancer-mediated bacterial dysbiosis [69]. This evidence concerns the gene CRP and lung cancer.